Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy

Obstetrics and Gynecology

Volumn 107, Issue 1, 2006, Pages 106-114

  Dann, Anthony T ^b   Kenyon, Anna P ^b   Wierzbicki, Anthony S ^b   Seed, Paul T ^b   Shennan, Andrew H ^b   Tribe, Rachel M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; BIOLOGICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EARLY DIAGNOSIS; FEMALE; GESTATION PERIOD; HUMAN; INTRAHEPATIC CHOLESTASIS; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PATHOGENESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PRURITUS; PRURITUS GRAVIDARUM; PUERPERIUM; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; GESTATIONAL AGE; INCIDENCE; LIPID METABOLISM; MATERNAL AGE; METHODOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; PROBABILITY; RISK ASSESSMENT;

ADULT; CASE-CONTROL STUDIES; CHOLESTASIS, INTRAHEPATIC; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; LIPID METABOLISM; MATERNAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; PROBABILITY; RISK ASSESSMENT;

EID: 33644863974     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000189096.94874.9c     Document Type: Article

References (35)

1. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997;12:211-6.
2. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000;33:1012-21.
3. Raine-Fenning N, Kilby M. Obstetric cholestasis. Fetal and Maternal Medical Reviews 1997;9:1-17.
4. Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988;95:1137-43.
5. Reyes H, Gonzalez MC, Ribalta J, Aburto H, Matus C, Schramm G, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med 1978;88:487-93.
6. Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999;141:71-81.
7. Ikonen E. Jaundice in late pregnancy. Acta Obstet Gynecol Scand 1964;43 suppl:1-130.
8. Dalen E, Westerholm B. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters. Acta Med Scand 1974;195:459-63.
9. Johnson P. Studies in cholestasis of pregnancy with special reference to lipids and lipoproteins. Acta Obstet Gynecol Scand Suppl 1973;27:1-80.
10. Reyes H. The spectrum of liver and gastrointestinal disease seen in cholestasis of pregnancy. Gastroenterol Clin North Am 1992;21:905-21.
11. Nikkila K, Riikonen S, Lindfors M, Miettinen TA. Serum squalene and noncholesterol sterols before and after delivery in normal and cholestatic pregnancy. J Lipid Res 1996;37:2687-95.
12. Wojcicka J, Sienko J, Smolarczyk R, Romejko E, Grymowicz M, Czajkowski K. Alpha-hydroxybutyrate dehydrogenase activity in intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2005;89:247-50.
13. Barter P. HDL: a recipe for longevity. Atheroscler Suppl 2004;5:25-31.
14. Schachter D. Fluidity and function of hepatocyte plasma membranes. Hepatology 1984;4:140-51.
15. Reyes H, Simon FR. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993;13:289-301.
16. Vore M. Estrogen cholestasis: membranes, metabolites, or receptors? Gastroenterology 1987;93:643-9.
17. Burrows RF, Clavisi O, Burrows E. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev 2001;4:CD000493.
18. Poupon RE, Ouguerram K, Chretien Y, Verneau C, Eschwege E, Magot T, et al. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology 1993;17:577-82.
19. Dann AT, Kenyon AP, Seed PT, Poston L, Shennan AH, Tribe RM. Glutathione-S-transferase and liver function in intrahepatic cholestasis of pregnancy and pruritus gravidarum. Hepatology 2004;40:1406-14.
20. Girling JC, Dow E, Smith JH. Liver function tests in preeclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997;104:246-50.
21. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse when interpreting results. Ann Intern Med 1994;121:200-6.
22. Box GE, Cox DR. An analysis of transformations. J R Stat Soc 1964;26:211-43.
23. Amemiya T. Regression analysis when the dependent variable is truncated normal. Econometrica 1973;41:997-1016.
24. Liang KY, Zeiger SL. Longitudinal analysis using generalised linear models. Biometrika 1986;73:13-22.
25. Binder DA. On the variances of asymptotically normal estimators from complex surveys. Int Stat Rev 1983;51:279-92.
26. Sterne JA, Davey Smith G. Sifting the Evidence-what's wrong with significance tests? BMJ 2001;322:226-31.
27. Piechota W, Staszewski A. Reference ranges of lipids and apolipoproteins in pregnancy. Eur J Obstet Gynecol Reprod Biol 1992;45:27-35.
28. Forkman B, Ganrot PO, Gennser G, Rannevik G. Plasma protein pattern in recurrent cholestasis of pregnancy. Scand J Clin Lab Invest Suppl 1972;124:89-96.
29. Johnson P, Samsioe G, Gustafson A. Studies in cholestasis of pregnancy. Acta Obstet Gynecol Scand 1975;54:105-11.
30. Svanborg A, Vikrot O. Plasma lipids in recurrent jaundice of pregnancy. Acta Med Scand 1967;181:83-7.
31. Srivastava RA, Srivastava N, Averna M. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Eur J Biochem 2000;267:4272-80.
32. Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 2002;109:961-71.
33. Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, et al. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A 1994;91:8724-8.
34. Heikkinen J, Maentausta O, Ylostalo P, Janne O. Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 1981;88:240-5.
35. Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, Di Leo, A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 1996;52:133-40.